Bioadaptives, Inc. (BDPT) financial statements (2021 and earlier)

Company profile

Business Address 1015 S CIMARRON RD
LAS VEGAS, NV 89145
State of Incorp. DE
Fiscal Year End December 31
SIC 677 - Blank Checks (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
12/31/2019
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments513568119
Cash and cash equivalents51203819
Short-term investments01530100
Inventory, net of allowances, customer advances and progress billings1411  
Inventory1411   
Deposits current assets  222
Total current assets:1924770120
Noncurrent Assets
Property, plant and equipment  11 
Total noncurrent assets:  11 
TOTAL ASSETS:1924771120
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:8830343 
Accounts payable  343 
Accrued liabilities 0   
Interest and dividends payable   1 
Other undisclosed accounts payable and accrued liabilities8830   
Debt4057   
Derivative instruments and hedges, liabilities827    
Due to related parties78501512632
Other undisclosed current liabilities 7772541 
Total current liabilities:1,3988642117132
Noncurrent Liabilities
Total liabilities:1,3988642117132
Stockholders' equity
Stockholders' equity attributable to parent, including:(1,379)(840)(203)(0)88
Common stock22111
Additional paid in capital4,2253,9172,6732,624206
Accumulated other comprehensive loss  (57)(31)(100)
Accumulated deficit(5,606)(4,759)(2,821)(2,594) 
Other undisclosed stockholders' equity attributable to parent    (18)
Total stockholders' equity:(1,379)(840)(203)(0)88
TOTAL LIABILITIES AND EQUITY:1924771120

Income statement (P&L) ($ in thousands)

12/31/2020
12/31/2019
12/31/2015
12/31/2014
12/31/2013
Revenues1610 0 
Other income   0
Cost of revenue(10)(5)   
Gross profit:65 0 
Operating expenses(260)(239)(227)(2,436) 
Other operating expense, net
(Other Expenses)
(593)    
Other undisclosed operating loss   (0) 
Operating loss:(847)(234)(227)(2,436) 
Nonoperating expense (5)(0)(139) 
Investment income, nonoperating (198)   
Interest and debt expense133199(0)(1) 
Loss from continuing operations before equity method investments, income taxes:(715)(40)(228)(2,576) 
Other undisclosed loss from continuing operations before income taxes(133)(199)   
Net loss:(847)(239)(228)(2,576) 
Other undisclosed net income attributable to parent  01 
Net loss available to common stockholders, diluted:(847)(239)(227)(2,575) 

Comprehensive Income ($ in thousands)

12/31/2020
12/31/2019
12/31/2015
12/31/2014
12/31/2013
Net loss:(847)(239)(228)(2,576) 
Comprehensive loss:(847)(239)(228)(2,576) 
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  (25)69 
Comprehensive loss, net of tax, attributable to parent:(847)(239)(253)(2,507) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: